BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Symetis is defunct.

Fate: Acquired by Boston Scientific, May 2017, $435M


------------------
If you believe any of this information is incorrect, please let us know.